Advertisement

Mortality Risk Comparable With Continuous Versus Intermittent ADT for Prostate Cancer

Nov 14, 2023

REFERENCES & ADDITIONAL READING

Comparison of Intermittent and Continuous Androgen Deprivation Therapy in Prostate Cancer Patients: An Up-to-Date Meta-analysis for Urologists and Medical Providers https://www.auajournals.org/doi/10.1097/UPJ.0000000000000424

ABOUT THE EXPERTS

  • Werner de Riese, MD, PhD

    Professor
    Department of Urology
    Texas Tech University Health Sciences Center

    Werner de Riese, MD, PhD, has indicated to Physician’s Weekly that he has no financial interests to disclose.

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement